LOXL2 and cancer: For example, exploration of epigenetic mechanisms that regulate fibroblast activity in cancer point to the role of miR-29a and its direct effect on both LOXL2 and serpin peptidase inhibitor clade H, member 1 (SERPINH1) [25].